Europe Erythropoietin Drugs Industry 2016 Deep Market Research Report
- QYR642784
- 118 Pages
- August 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Erythropoietin Drugs market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Erythropoietin Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 147 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Definition and Specifications of Erythropoietin Drugs
1.1.1 Definition of Erythropoietin Drugs
1.1.2 Specifications of Erythropoietin Drugs
1.2 Classification of Erythropoietin Drugs
1.3 Applications of Erythropoietin Drugs
1.4 Industry Chain Structure of Erythropoietin Drugs
1.5 Industry Overview of Erythropoietin Drugs
1.6 Industry Policy Analysis of Erythropoietin Drugs
1.7 Industry News Analysis of Erythropoietin Drugs
2 Manufacturing Cost Structure Analysis of Erythropoietin Drugs
2.1 Bill of Materials (BOM) of Erythropoietin Drugs
2.2 BOM Price Analysis of Erythropoietin Drugs
2.3 Labor Cost Analysis of Erythropoietin Drugs
2.4 Depreciation Cost Analysis of Erythropoietin Drugs
2.5 Manufacturing Cost Structure Analysis of Erythropoietin Drugs
2.6 Manufacturing Process Analysis of Erythropoietin Drugs
2.7 Europe Price, Cost and Gross of Erythropoietin Drugs 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Europe Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Europe Key Erythropoietin Drugs Manufacturers in 2015
3.3 R&D Status and Technology Source of Europe Erythropoietin Drugs Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Europe Erythropoietin Drugs Key Manufacturers in 2015
4 Production Analysis of Erythropoietin Drugs by Regions, Type, and Applications
4.1 Europe Production of Erythropoietin Drugs by Regions 2011-2016
4.2 Europe Production of Erythropoietin Drugs by Type 2011-2016
4.3 Europe Sales of Erythropoietin Drugs by Applications 2011-2016
4.4 Price Analysis of Europe Erythropoietin Drugs Key Manufacturers in 2015
4.5 Europe Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Erythropoietin Drugs 2011-2016
5 Consumption Volume and Consumption Value Analysis of Erythropoietin Drugs by Regions
5.1 Europe Consumption Volume of Erythropoietin Drugs by Regions 2011-2016
5.2 Europe Consumption Value of Erythropoietin Drugs by Regions 2011-2016
5.3 Europe Consumption Price Analysis of Erythropoietin Drugs by Regions 2011-2016
6 Analysis of Erythropoietin Drugs Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Erythropoietin Drugs 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Erythropoietin Drugs 2014-2015
6.3 Sales Overview of Erythropoietin Drugs 2011-2016
6.4 Supply, Consumption and Gap of Erythropoietin Drugs 2011-2016
6.5 Import, Export and Consumption of Erythropoietin Drugs 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Erythropoietin Drugs 2011-2016
7 Analysis of Erythropoietin Drugs Industry Key Manufacturers
7.1 Amgen
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information
7.2 Johnson and Johnson
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information
7.3 Roche
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information
7.4 Pfizer
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information
7.5 LG Life Sciences
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information
7.6 Biocon
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.2.1 Type I
7.6.2.2 Type II
7.6.2.3 Type III
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
7.6.4 Contact Information
7.7 Intas Pharmaceuticals
7.7.1 Company Profile
7.7.2 Product Picture and Specifications
7.7.2.1 Type I
7.7.2.2 Type II
7.7.2.3 Type III
7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
7.7.4 Contact Information
7.8 Teva Pharmaceutical Industries
7.8.1 Company Profile
7.8.2 Product Picture and Specifications
7.8.2.1 Type I
7.8.2.2 Type II
7.8.2.3 Type III
7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
7.8.4 Contact Information
7.9 Sun Pharmaceutical Industries
7.9.1 Company Profile
7.9.2 Product Picture and Specifications
7.9.2.1 Type I
7.9.2.2 Type II
7.9.2.3 Type III
7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
7.9.4 Contact Information
7.10 Celltrion
7.10.1 Company Profile
7.10.2 Product Picture and Specifications
7.10.2.1 Type I
7.10.2.2 Type II
7.10.2.3 Type III
7.10.3 Capacity, Production, Price, Cost, Gross and Revenue
7.10.4 Contact Information
...
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Erythropoietin Drugs Product Types
8.5 Market Share Analysis of Different Erythropoietin Drugs Price Levels
8.6 Gross Margin Analysis of Different Erythropoietin Drugs Applications
9 Marketing Trader or Distributor Analysis of Erythropoietin Drugs
9.1 Marketing Channels Status of Erythropoietin Drugs
9.2 Traders or Distributors of Erythropoietin Drugs with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Erythropoietin Drugs
9.4 Europe Import, Export and Trade Analysis of Erythropoietin Drugs
10 Development Trend of Erythropoietin Drugs Industry 2016-2021
10.1 Capacity and Production Overview of Erythropoietin Drugs 2016-2021
10.2 Production Market Share by Product Types of Erythropoietin Drugs 2016-2021
10.3 Sales and Sales Revenue Overview of Erythropoietin Drugs 2016-2021
10.4 Europe Sales of Erythropoietin Drugs by Applications 2016-2021
10.5 Import, Export and Consumption of Erythropoietin Drugs 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Erythropoietin Drugs 2016-2021
11 Industry Chain Suppliers of Erythropoietin Drugs with Contact Information
11.1 Major Raw Materials Suppliers of Erythropoietin Drugs with Contact Information
11.2 Manufacturing Equipment Suppliers of Erythropoietin Drugs with Contact Information
11.3 Major Players of Erythropoietin Drugs with Contact Information
11.4 Key Consumers of Erythropoietin Drugs with Contact Information
11.5 Supply Chain Relationship Analysis of Erythropoietin Drugs
12 New Project Investment Feasibility Analysis of Erythropoietin Drugs
12.1 New Project SWOT Analysis of Erythropoietin Drugs
12.2 New Project Investment Feasibility Analysis of Erythropoietin Drugs
13 Conclusion of the Europe Erythropoietin Drugs Industry 2016 Market Research Report
Figure Picture of Erythropoietin Drugs
Table Product Specifications of Erythropoietin Drugs
Table Classification of Erythropoietin Drugs
Figure Europe Sales Market Share of Erythropoietin Drugs by Product Types in 2015
Table Applications of Erythropoietin Drugs
Figure Europe Sales Market Share of Erythropoietin Drugs by Applications in 2015
Figure Industry Chain Structure of Erythropoietin Drugs
Table Europe Industry Overview of Erythropoietin Drugs
Table Industry Policy of Erythropoietin Drugs
Table Industry News List of Erythropoietin Drugs
Table Bill of Materials (BOM) of Erythropoietin Drugs
Table Bill of Materials (BOM) Price of Erythropoietin Drugs
Table Labor Cost of Erythropoietin Drugs
Table Depreciation Cost of Erythropoietin Drugs
Table Manufacturing Cost Structure Analysis of Erythropoietin Drugs in 2015
Figure Manufacturing Process Analysis of Erythropoietin Drugs
Table Europe Price Analysis of Erythropoietin Drugs 2011-2016 (USD/Unit)
Table Europe Cost Analysis of Erythropoietin Drugs 2011-2016 (USD/Unit)
Table Europe Gross Analysis of Erythropoietin Drugs 2011-2016
Table Capacity (K Units) and Commercial Production Date of Europe Erythropoietin Drugs Key Manufacturers in 2015
Table Manufacturing Plants Distribution of Europe Key Erythropoietin Drugs Manufacturers in 2015
Table R&D Status and Technology Source of Europe Erythropoietin Drugs Key Manufacturers in 2015
Table Raw Materials Sources Analysis of Europe and Europe Erythropoietin Drugs Key Manufacturers in 2015
Table Europe Production of Erythropoietin Drugs by Regions 2011-2016 (K Units)
Table Europe Production Market Share of Erythropoietin Drugs by Regions 2011-2016
Figure Europe Production Market Share of Erythropoietin Drugs by Regions in 2014
Figure Europe Production Market Share of Erythropoietin Drugs by Regions in 2015
Table Europe Production of Erythropoietin Drugs by Types in 2011-2016 (K Units)
Table Europe Production Market Share of Erythropoietin Drugs by Type in 2011-2016
Figure Europe Production Market Share of Erythropoietin Drugs by Type in 2014
Figure Europe Production Market Share of Erythropoietin Drugs by Type in 2015
Table Europe Sales of Erythropoietin Drugs by Applications 2011-2016 (K Units)
Table Europe Production Market Share of Erythropoietin Drugs by Applications 2011-2016
Figure Europe Production Market Share of Erythropoietin Drugs by Applications in 2014
Figure Europe Production Market Share of Erythropoietin Drugs by Applications in 2015
Table Price Comparison of Europe Erythropoietin Drugs Key Manufacturers in 2015 (USD/Unit)
Table Europe Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Erythropoietin Drugs 2011-2016
Table Europe Consumption Volume of Erythropoietin Drugs by Regions 2011-2016 (K Units)
Table Europe Consumption Volume Market Share of Erythropoietin Drugs by Regions 2011-2016
Figure Europe Consumption Volume Market Share of Erythropoietin Drugs by Regions in 2014
Figure Europe Consumption Volume Market Share of Erythropoietin Drugs by Regions in 2015
Table Europe Consumption Value of Erythropoietin Drugs by Regions 2011-2016 (M USD)
Table Europe Consumption Value Market Share of Erythropoietin Drugs by Regions 2011-2016
Figure Europe Consumption Value Market Share of Erythropoietin Drugs by Regions in 2014
Figure Europe Consumption Value Market Share of Erythropoietin Drugs by Regions in 2015
Table Consumption Price of Erythropoietin Drugs by Regions 2011-2016 (USD/Unit)
Table Europe and Major Manufacturers Capacity of Erythropoietin Drugs 2011-2016 (K Units)
Table Europe Capacity Market Share of Major Erythropoietin Drugs Manufacturers 2011-2016
Table Europe and Major Manufacturers Production of Erythropoietin Drugs 2011-2016 (K Units)
Table Europe Production Market Share of Major Erythropoietin Drugs Manufacturers 2011-2016
Table Europe and Major Manufacturers Sales of Erythropoietin Drugs 2011-2016 (K Units)
Table Europe Sales Market Share of Major Erythropoietin Drugs Manufacturers 2011-2016
Table Europe and Major Manufacturers Sales Revenue of Erythropoietin Drugs 2011-2016 (M USD)
Table Europe Sales Revenue Market Share of Major Erythropoietin Drugs Manufacturers 2011-2016
Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Erythropoietin Drugs 2011-2016
Figure Europe Capacity Utilization Rate of Erythropoietin Drugs 2011-2016
Figure Europe Sales Revenue (M USD) and Growth Rate of Erythropoietin Drugs 2011-2016
Figure Europe Production Market Share of Major Erythropoietin Drugs Manufacturers in 2014
Figure Europe Production Market Share of Major Erythropoietin Drugs Manufacturers in 2015
Figure Europe Sales Market Share of Major Erythropoietin Drugs Manufacturers in 2014
Figure Europe Sales Market Share of Major Erythropoietin Drugs Manufacturers in 2015
Figure Europe Sales (K Units) and Growth Rate of Erythropoietin Drugs 2011-2016
Table Europe Supply, Consumption and Gap of Erythropoietin Drugs 2011-2016 (K Units)
Table Europe Import, Export and Consumption of Erythropoietin Drugs 2011-2016 (K Units)
Table Price of Europe Erythropoietin Drugs Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of Europe Erythropoietin Drugs Major Manufacturers 2011-2016
Table Europe and Major Manufacturers Revenue of Erythropoietin Drugs 2011-2016 (M USD)
Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Erythropoietin Drugs 2011-2016
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drugs Picture and Specifications of Amgen
Table Erythropoietin Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2011-2016
Figure Erythropoietin Drugs Capacity (K Units), Production (K Units) and Growth Rate of Amgen 2011-2016
Figure Erythropoietin Drugs Production (K Units) and Europe Market Share of Amgen 2011-2016
Table Amgen Erythropoietin Drugs SWOT Analysis
Table Johnson and Johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drugs Picture and Specifications of Johnson and Johnson
Table Erythropoietin Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Johnson and Johnson 2011-2016
Figure Erythropoietin Drugs Capacity (K Units), Production (K Units) and Growth Rate of Johnson and Johnson 2011-2016
Figure Erythropoietin Drugs Production (K Units) and Europe Market Share of Johnson and Johnson 2011-2016
Table Johnson and Johnson Erythropoietin Drugs SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drugs Picture and Specifications of Roche
Table Erythropoietin Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Roche 2011-2016
Figure Erythropoietin Drugs Capacity (K Units), Production (K Units) and Growth Rate of Roche 2011-2016
Figure Erythropoietin Drugs Production (K Units) and Europe Market Share of Roche 2011-2016
Table Roche Erythropoietin Drugs SWOT Analysis
Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drugs Picture and Specifications of Pfizer
Table Erythropoietin Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2011-2016
Figure Erythropoietin Drugs Capacity (K Units), Production (K Units) and Growth Rate of Pfizer 2011-2016
Figure Erythropoietin Drugs Production (K Units) and Europe Market Share of Pfizer 2011-2016
Table Pfizer Erythropoietin Drugs SWOT Analysis
Table LG Life Sciences Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drugs Picture and Specifications of LG Life Sciences
Table Erythropoietin Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of LG Life Sciences 2011-2016
Figure Erythropoietin Drugs Capacity (K Units), Production (K Units) and Growth Rate of LG Life Sciences 2011-2016
Figure Erythropoietin Drugs Production (K Units) and Europe Market Share of LG Life Sciences 2011-2016
Table LG Life Sciences Erythropoietin Drugs SWOT Analysis
Table Biocon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drugs Picture and Specifications of Biocon
Table Erythropoietin Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biocon 2011-2016
Figure Erythropoietin Drugs Capacity (K Units), Production (K Units) and Growth Rate of Biocon 2011-2016
Figure Erythropoietin Drugs Production (K Units) and Europe Market Share of Biocon 2011-2016
Table Biocon Erythropoietin Drugs SWOT Analysis
Table Intas Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drugs Picture and Specifications of Intas Pharmaceuticals
Table Erythropoietin Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Intas Pharmaceuticals 2011-2016
Figure Erythropoietin Drugs Capacity (K Units), Production (K Units) and Growth Rate of Intas Pharmaceuticals 2011-2016
Figure Erythropoietin Drugs Production (K Units) and Europe Market Share of Intas Pharmaceuticals 2011-2016
Table Intas Pharmaceuticals Erythropoietin Drugs SWOT Analysis
Table Teva Pharmaceutical Industries Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drugs Picture and Specifications of Teva Pharmaceutical Industries
Table Erythropoietin Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva Pharmaceutical Industries 2011-2016
Figure Erythropoietin Drugs Capacity (K Units), Production (K Units) and Growth Rate of Teva Pharmaceutical Industries 2011-2016
Figure Erythropoietin Drugs Production (K Units) and Europe Market Share of Teva Pharmaceutical Industries 2011-2016
Table Teva Pharmaceutical Industries Erythropoietin Drugs SWOT Analysis
Table Sun Pharmaceutical Industries Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drugs Picture and Specifications of Sun Pharmaceutical Industries
Table Erythropoietin Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sun Pharmaceutical Industries 2011-2016
Figure Erythropoietin Drugs Capacity (K Units), Production (K Units) and Growth Rate of Sun Pharmaceutical Industries 2011-2016
Figure Erythropoietin Drugs Production (K Units) and Europe Market Share of Sun Pharmaceutical Industries 2011-2016
Table Sun Pharmaceutical Industries Erythropoietin Drugs SWOT Analysis
Table Celltrion Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drugs Picture and Specifications of Celltrion
Table Erythropoietin Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Celltrion 2011-2016
Figure Erythropoietin Drugs Capacity (K Units), Production (K Units) and Growth Rate of Celltrion 2011-2016
Figure Erythropoietin Drugs Production (K Units) and Europe Market Share of Celltrion 2011-2016
Table Celltrion Erythropoietin Drugs SWOT Analysis
Table Erythropoietin Drugs Price by Regions 2011-2016
Table Erythropoietin Drugs Price by Product Types 2011-2016
Table Erythropoietin Drugs Price by Companies 2011-2016
Table Erythropoietin Drugs Gross Margin by Companies 2011-2016
Table Price Comparison of Erythropoietin Drugs by Regions 2011-2016 (USD/Unit)
Table Price of Different Erythropoietin Drugs Product Types (USD/Unit)
Table Market Share of Different Erythropoietin Drugs Price Level
Table Gross Margin of Different Erythropoietin Drugs Applications
Table Marketing Channels Status of Erythropoietin Drugs
Table Traders or Distributors of Erythropoietin Drugs with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Erythropoietin Drugs (USD/Unit) in 2015
Table Europe Import, Export, and Trade of Erythropoietin Drugs (K Units)
Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Erythropoietin Drugs 2016-2021
Figure Europe Capacity Utilization Rate of Erythropoietin Drugs 2016-2021
Table Europe Erythropoietin Drugs Production by Type 2016-2021 (K Units)
Table Europe Erythropoietin Drugs Production Market Share by Type 2016-2021
Figure Europe Production Market Share of Erythropoietin Drugs by Type in 2021
Figure Europe Sales (K Units) and Growth Rate of Erythropoietin Drugs 2016-2021
Figure Europe Sales Revenue (Million USD) and Growth Rate of Erythropoietin Drugs 2016-2021
Figure Europe Sales of Erythropoietin Drugs by Applications 2016-2021 (K Units)
Table Europe Production Market Share of Erythropoietin Drugs by Applications 2016-2021
Figure Europe Production Market Share of Erythropoietin Drugs by Applications in 2021
Table Europe Production, Import, Export and Consumption of Erythropoietin Drugs 2016-2021 (K Units)
Table Europe Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Erythropoietin Drugs 2016-2021
Table Major Raw Materials Suppliers of Erythropoietin Drugs with Contact Information
Table Manufacturing Equipment Suppliers of Erythropoietin Drugs with Contact Information
Table Major Players of Erythropoietin Drugs with Contact Information
Table Key Consumers of Erythropoietin Drugs with Contact Information
Table Supply Chain Relationship Analysis of Erythropoietin Drugs
Table New Project SWOT Analysis of Erythropoietin Drugs
Table New Project Investment Feasibility Analysis of Erythropoietin Drugs
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
